Table 2.

Prevalence of anticoagulatory medication and comorbidities in the deceased.

	Total	DC	CO
Patients [n]	299	136	163
LOS [h, mean ± SD]	294 h ± 459 h	279 h ± 375 h	307 h ± 520 h
Anticoagulatory medication
DOAC or VKA	59 [20%]	19 [14%]	40 [25%]
Antiplatelet therapy	40 [13%]	16 [12%]	24 [15%]
Comorbidities
Arterial hypertension	60 [20%]	22 [16%]	38 [23%]
Atrial fibrillation	47 [16%]	17 [13%]	30 [18%]
PAD, CSVD or CAD	49 [16%]	22 [16%]	27 [17%]
Solid malignancies	26 [9%]	10 [7%]	16 [10%]
Leukemia or lymphoma	20 [7%]	9 [7%]	11 [7%]
Chronic kidney disease	13 [4%]	5 [4%]	8 [5%]
Heart failure (NYHA ≥ 3)	6 [2.0%]	2 [1.5%]	4 [2.5%]
Liver cirrhosis	5 [1.7%]	2 [1.5%]	3 [1.8%]
Thromboembolic disease	3 [1.0%]	2 [1.5%]	1 [0.6%]

DC decompressive craniectomy, CO craniotomy, LOS length of stay, DOAC direct oral anticoagulants, VKA vitamin K antagonists, PAD peripheral artery disease, CSVD cerebral small vessel disease, CAD coronary artery disease.